The neonicotinoid imidacloprid impairs the predatory performance and functional response of the jumping spider Helpis minitabunda (Araneae, Salticidae)

Posted by
  The neonicotinoid imidacloprid impairs the predatory performance and functional response of the jumping spider Helpis minitabunda (Araneae, Salticidae) Abstract The neonicotinoid imidacloprid can cause lethal and sublethal effects in non-target organisms, including impaired behavior, reduced fertility, disrupted locomotion, and reduced predatory performance in arthropods. Spiders are among the most abundant arthropod predators in terrestrial ecosystems, including agricultural ecosystems, yet the effects of neonicotinoids on the predatory function of jumping spiders remain poorly understood. The functional response of a predator describes how predation rates change with prey density and is key to understanding predator–prey dynamics. We tested whether acute exposure to a commercial formulation of imidacloprid at field-recommended concentrations alters the functional response of the Aussie bronze jumping spider, Helpis minitabunda (L. Koch, 1880). We compared the predation of treat...

Anti-Toxoplasma gondii studies of the venom peptide XYP4 from the Lycosa coelestis

Posted by

 


Anti-Toxoplasma gondii studies of the venom peptide XYP4 from the Lycosa coelestis

Abstract

Toxoplasma gondii (T. gondii) is an intracellular parasite with multiple routes of infection that poses a serious health risk to pregnant women, fetuses, and immunocompromised populations. Currently, clinical drugs in the treatment of toxoplasmosis continue to face challenges such as drug resistance. In the face of this challenge, researchers have gradually focused on the potential medicinal value of animal venoms in the fight against T. gondii, especially venom peptides showing advantages such as high potency, membrane targeting, and immunomodulation. The present study aimed to explore whether XYP4, a peptide derived from the venom of the Lycosa coelestis (L. coelestis), possesses better anti-T. gondii activity and its mode of action. The experimental results showed that XYP4 is an amphiphilic cationic linear polypeptide with an α-helix, which can exert anti-toxoplasma activity at low concentrations, affecting the lytic cycle. This polypeptide showed moderate survival benefits in mice infected with T. gondii. The main modes of action of XYP4 include inhibition of tachyzoites' intracellular proliferation, modulation of inflammatory factor expression in the host cells, and disruption of tachyzoite membrane integrity.
Yang, D., Liu, X., Li, J., Wu, K., Xie, J., Wang, Y., Wang, Z., & Jiang, L. (2025). Anti-Toxoplasma gondii studies of the venom peptide XYP4 from the Lycosa coelestis. Toxicon, 108540. https://doi.org/10.1016/j.toxicon.2025.108540